Cullinan Therapeutics (CGEM) EPS (Basic) (2020 - 2026)
Cullinan Therapeutics' (CGEM) quarterly EPS (Basic) came in at -$2.45 in Q1 2026, up 1.53% year-on-year from -$2.42 in Q1 2025, and down 2.03% quarter-over-quarter from -$2.41 in Q4 2025.
Cullinan Therapeutics (CGEM) EPS (Basic) (2020 - 2026) Analysis & Trends
Cullinan Therapeutics' EPS (Basic) history runs 7 years deep, the most recent figure standing at -$2.45 for Q1 2026.
- On a quarterly basis, EPS (Basic) rose 1.53% year-over-year to -$2.45 in Q1 2026; TTM through Mar 2026 was -$10.54, a 34.18% increase from a year earlier, with the FY2025 full-year figure at -$10.44, down 24.53% from the prior year.
- EPS (Basic) fell to -$2.45 in Q1 2026 per CGEM's latest filing, from -$2.41 in the prior quarter.
- Across five years, EPS (Basic) topped out at $3.88 in Q2 2022 and bottomed at -$11.32 in Q4 2024.
- The 5-year median for EPS (Basic) is -$0.95 (2024), against an average of -$1.71.
- Biggest YoY gain for EPS (Basic) was 1121.63% in 2022; the steepest drop was 958.34% in 2022.
- Year by year, EPS (Basic) stood at -$0.6 in 2022, then plunged by 116.16% to -$1.29 in 2023, then sank by 774.73% to -$11.32 in 2024, then jumped by 78.76% to -$2.41 in 2025, then retreated by 2.03% to -$2.45 in 2026.
- Per Business Quant, the three latest CGEM EPS (Basic) figures stand at -$2.45 (Q1 2026), -$2.41 (Q4 2025), and -$2.47 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.16 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 0.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 0.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -2.29 |
| 10 | Cullinan Therapeutics | 368.65 Mn | 368.65 Mn | - | -2.45 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.45 |
| Dec 31, 2025 | -2.41 |
| Sep 30, 2025 | -2.47 |
| Jun 30, 2025 | -3.38 |
| Mar 31, 2025 | -2.49 |
| Dec 31, 2024 | -11.32 |
| Sep 30, 2024 | -0.70 |
| Jun 30, 2024 | -0.82 |
| Mar 31, 2024 | -0.95 |
| Dec 31, 2023 | -1.29 |
| Sep 30, 2023 | -0.92 |
| Jun 30, 2023 | -0.81 |
| Mar 31, 2023 | -1.43 |
| Dec 31, 2022 | -0.60 |
| Sep 30, 2022 | -0.55 |
| Jun 30, 2022 | 3.88 |
| Mar 31, 2022 | -0.29 |
| Dec 31, 2021 | -0.79 |
| Sep 30, 2021 | -0.42 |
| Jun 30, 2021 | -0.38 |